Journal of General Internal Medicine, 2012 Barry, Ladizinski, Kachiu Cecelia, Lee
openaire +2 more sources
Recalcitrant bullous pemphigoid responsive to dupilumab in an adolescent patient
JAAD Case Reports, 2022 Albert E. Zhou, MD, PhD +3 more
doaj +1 more source
Mucosal Involvement in Bullous Pemphigoid: Severity Indicator and Associated Clinical Features from a Retrospective Cohort Study. [PDF]
J Inflamm ResCui S +6 more
europepmc +1 more source
Editorial: Autoimmune pre-disease
Frontiers in Immunology, 2023 Jennifer E. Hundt +5 more
doaj +1 more source
Peristomal bullous pemphigoid: expanding the spectrum of localized presentations. [PDF]
An Bras DermatolRamírez-Bravo F +5 more
europepmc +1 more source
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in an Elderly Woman With Type 2 Diabetes Mellitus: A Case Report. [PDF]
CureusRoa Alvarez G +4 more
europepmc +1 more source
Bullous Pemphigoid Following IgG/IgA Pemphigus: Possible Involvement of SGLT2 and DPP-4 Inhibitors. [PDF]
Acta Derm VenereolIkeda A +4 more
europepmc +1 more source
Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence. [PDF]
Front ImmunolLi X +5 more
europepmc +1 more source
Genetically Predicted t<sup>6</sup>A (a tRNA-Derived Adenosine Modification) and Risk of Bullous Pemphigoid: A Two-Sample Mendelian Randomization Study. [PDF]
Clin Cosmet Investig DermatolYan L, Chen D, Yu D, Shen X.
europepmc +1 more source